Global /China /Healthcare /Drug Manufacturers - General /000566

Hainan Haiyao Co., Ltd.

000566

• SHE: 000566 • Delayed

5.00CNY 0.8%

0.7388 USD

As of 16 June 2026, Hainan Haiyao Co., Ltd. has a market cap of $950.31M USD, ranking #11004 globally and #3123 in China. It ranks #987 in the Healthcare sector, and #368 in the Drug Manufacturers - General industry.

Global Rank

11004

Country Rank

3123

Sector Rank

987

Industry Rank

368

Key Stats

Market Cap

$950.31MUSD

6.43B CNY

Enterprise Value

$1.32BUSD

8.93B CNY

Revenue (TTM)

$117.08MUSD

792.76M CNY

EBITDA (TTM)

-$10.82MUSD

-73.24M CNY

Net Income (TTM)

-$64.7MUSD

-438.08M CNY

EBITDA Margin

-9.2%

Profit Margin

-55%

PS Ratio

8.1

PB Ratio

171.9

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Yong Tian open_in_new

Employees

1,738

Founded

1965

Website

haiyao.com.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.8%	-2.5%	-8.9%	-22%	-16%	-30%	4%	-1.8%	-18%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	000566 海南海药股份有限公司 Class A ISIN: CNE0000004W8 Shares Out.: Shares Outstanding: 1.165B¹ Shares Float: 648.222M² TV: TradingView: SZSE: 000566 SA: Stock Analysis: SHE: 000566 YF: Yahoo Finance: 000566.SZ GF: Google Finance: SHE: 000566 BA: Barron's: 000566 MS: Morningstar: XSHE: 000566	5.00 CNY	TV: TradingView: SZSE: 000566 SA: Stock Analysis: SHE: 000566 YF: Yahoo Finance: 000566.SZ GF: Google Finance: SHE: 000566 BA: Barron's: 000566 MS: Morningstar: XSHE: 000566

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Hainan Haiyao Co., Ltd.

Hainan Haiyao Co., Ltd. manufactures and sells pharmaceutical products and medical devices in China and internationally. The company offers big health, digestive, anti-infective, respiratory, anti-tumor, vitamins, and chronic disease category products. It also provides active pharmaceutical ingredients and intermediates; traditional Chinese medicine decoction pieces; medical devices, including disposable medical mask, implant, and source processor; and medical services. In addition, the company offers chemical drugs, modern traditional Chinese medicine, biopharmaceuticals, and cell immunotherapy. Hainan Haiyao Co., Ltd. was founded in 1965 and is headquartered in Haikou, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.89B 364.89B CNY 6K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.67B 336.36B CNY 5K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 3K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 2K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.52B 111.89B CNY 2K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 2K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 80K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 57K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 38K%	97.4	United States
Roche Holding AG SIX: RO	$320.51B 256.25B CHF 34K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.14B 215.59B GBP 30K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 29K%	15.1	United States

chevron_leftBack